Cargando…
The role of epigenetics in T-cell lymphoma
Malignant lymphomas are a group of diseases with epigenomic abnormalities fundamental to pathogenesis and pathophysiology. They are characterized by a high frequency of abnormalities related to DNA methylation regulators (DNMT3A, TET2, IDH2, etc.) and histone modifiers (EZH2, HDAC, KMT2D/MLL2, CREBB...
Autor principal: | Yamagishi, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668792/ https://www.ncbi.nlm.nih.gov/pubmed/36239901 http://dx.doi.org/10.1007/s12185-022-03470-1 |
Ejemplares similares
-
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy
por: Russell, Brian M., et al.
Publicado: (2023) -
Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cells
por: Fujiwara, Hiroshi
Publicado: (2021) -
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
por: Biavasco, Francesca, et al.
Publicado: (2022) -
Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine
por: Wang, Xiuli, et al.
Publicado: (2021) -
Multiple myeloma with high-risk cytogenetics and its treatment approach
por: Hanamura, Ichiro
Publicado: (2022)